http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014047782-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a645d2f4b7504a36eaccfae5d3cbd70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
filingDate 2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dd421e0bbfd85520faa550652286db1
publicationDate 2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014047782-A1
titleOfInvention Pharmaceutical composition containing resveratrol and resveratrol derivative and bcl-2 inhibitor and use thereof
abstract Provided in the present invention are a pharmaceutical composition containing resveratrol and resveratrol derivative and the use thereof in the preparation of medicine for treating colon cancer, liver cancer, lung cancer, kidney cancer, gastric cancer, brain tumours, sarcoma, glioma, pancreatic cancer, ovarian cancer, breast cancer or prostate cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4209213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018031604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023131576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018031554-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3430057-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10822533-B2
priorityDate 2012-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128542940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127396589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID323857103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246479461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322581482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID326108298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25059310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322394633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127815391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128981706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID326703168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245589042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325207239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244379029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322939278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322542544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246164913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325158581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243737095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325667408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322614008

Total number of triples: 49.